Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.50 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | ACLY | P53396 | 3/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17697650 | 0.90 | SLC6A9 (0.51) | SLC6A9EGFRMEN1KMT2AMAPT | |
| SCHEMBL17720767 | 0.87 | EGFR (0.55) | KDM4ESLC6A9EGFRHPGDHSD17B10 | |
| SCHEMBL28530768 | 0.84 | PTGDR2 (0.58) | KDM4ESLC6A9HPGDHSD17B10MEN1 | |
| SCHEMBL25257345 | 0.84 | SLC6A9 (0.47) | KDM4ESLC6A9EGFRMEN1KMT2A | |
| SCHEMBL10429619 | 0.83 | BACE1 (0.61) | KDM4ESLC6A9EGFRHPGDHSD17B10 | |
| SCHEMBL1834873 | 0.83 | KDM4E (0.61) | KDM4EHPGDHSD17B10MEN1KMT2A | |
| SCHEMBL17697651 | 0.83 | SLC6A9 (0.51) | SLC6A9EGFRMEN1KMT2AMAPT | |
| SCHEMBL16395376 | 0.82 | BACE1 (0.47) | KDM4EHPGDHSD17B10MEN1KMT2A | |
| SCHEMBL10496442 | 0.81 | BACE1 (0.63) | KDM4ESLC6A9HPGDHSD17B10MEN1 | |
| SCHEMBL17720805 | 0.81 | PDE4D (0.47) | KDM4EHPGDHSD17B10PTGDR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3012896-B1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND BIPHENYL GROUP-CONTAINING CARBONATE COMPOUND USED IN SAME | UBE INDUSTRIES (JP) | 2018-03-28 | — | — | EP | claimed |
| US-20160126593-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND BIPHENYL GROUP-CONTAINING CARBONATE COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2016-05-05 | — | — | US | claimed |
| US-20160126593-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND BIPHENYL GROUP-CONTAINING CARBONATE COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20160126593-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND BIPHENYL GROUP-CONTAINING CARBONATE COMPOUND USED IN SAME | UBE INDUSTRIES, LTD. (JP) | 2016-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126593-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND BIPHENYL GROUP-CONTAINING CARBONATE COMPOUND USED IN SAME | BMI1, KCNN2, CACNA2D4 | KDM4E 39/4885SLC6A9 181/4885EGFR 1386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.